Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way
- 1 July 2016
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 303, 90-100
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanismsArchives of Toxicology, 2014
- PNPLA3 I148M polymorphism and progressive liver diseaseWorld Journal of Gastroenterology, 2013
- Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytesJournal of Hepatology, 2011
- Hepatic Expression of Thyroid Hormone-Responsive Spot 14 Protein Is Regulated by Constitutive Androstane Receptor (NR1I3)Endocrinology, 2010
- Activation of nuclear receptor CAR ameliorates diabetes and fatty liver diseaseProceedings of the National Academy of Sciences, 2009
- A Concentration Addition Model for the Activation of the Constitutive Androstane Receptor by Xenobiotic MixturesToxicological Sciences, 2008
- A case–control study of non-alcoholic fatty liver disease in breast cancerMedical Oncology, 2007
- Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouseWorld Journal of Gastroenterology, 2007
- Hepatic Glucokinase Is Required for the Synergistic Action of ChREBP and SREBP-1c on Glycolytic and Lipogenic Gene ExpressionJournal of Biological Chemistry, 2004
- Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbitalActa Neurologica Scandinavica, 1991